Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 7 studies | 22% ± 9% | |
epithelial cell | 4 studies | 27% ± 9% | |
basal cell | 3 studies | 28% ± 10% | |
secretory cell | 3 studies | 17% ± 1% | |
squamous epithelial cell | 3 studies | 44% ± 19% |
Insufficient scRNA-seq data for expression of SULT2B1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 74% | 1300.90 | 181 / 245 | 95% | 30.22 | 476 / 502 |
esophagus | 39% | 5096.71 | 564 / 1445 | 75% | 36.11 | 137 / 183 |
lung | 47% | 409.92 | 272 / 578 | 63% | 10.13 | 732 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 93% | 28.30 | 42 / 45 |
breast | 22% | 230.80 | 100 / 459 | 70% | 12.01 | 778 / 1118 |
intestine | 3% | 19.80 | 26 / 966 | 84% | 21.41 | 445 / 527 |
skin | 72% | 6652.76 | 1297 / 1809 | 10% | 3.57 | 45 / 472 |
stomach | 5% | 42.67 | 19 / 359 | 68% | 15.04 | 194 / 286 |
uterus | 3% | 158.76 | 5 / 170 | 68% | 23.92 | 311 / 459 |
pancreas | 0% | 0 | 0 / 328 | 66% | 8.33 | 117 / 178 |
bladder | 0% | 0 | 0 / 21 | 53% | 12.58 | 269 / 504 |
thymus | 1% | 7.83 | 7 / 653 | 49% | 4.48 | 295 / 605 |
ovary | 0% | 0 | 0 / 180 | 33% | 3.18 | 144 / 430 |
kidney | 8% | 94.02 | 7 / 89 | 2% | 0.20 | 18 / 901 |
liver | 0% | 0 | 0 / 226 | 7% | 1.22 | 28 / 406 |
adipose | 0% | 6.09 | 5 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 2.64 | 2 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0.01 | 1 / 705 |
peripheral blood | 0% | 1.20 | 1 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 2.75 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045606 | Biological process | positive regulation of epidermal cell differentiation |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0051923 | Biological process | sulfation |
GO_0050427 | Biological process | 3'-phosphoadenosine 5'-phosphosulfate metabolic process |
GO_0008202 | Biological process | steroid metabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_0051922 | Molecular function | cholesterol sulfotransferase activity |
GO_0050294 | Molecular function | steroid sulfotransferase activity |
GO_0015485 | Molecular function | cholesterol binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0036094 | Molecular function | small molecule binding |
GO_0008146 | Molecular function | sulfotransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_1990239 | Molecular function | steroid hormone binding |
Gene name | SULT2B1 |
Protein name | Sulfotransferase 2B1 (EC 2.8.2.2) (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1) (ST2B1) |
Synonyms | HSST2 |
Description | FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation. Responsible for the sulfation of cholesterol . Catalyzes sulfation of the 3beta-hydroxyl groups of steroids, such as, pregnenolone and dehydroepiandrosterone (DHEA) . Preferentially sulfonates cholesterol, while it has also significant activity with pregnenolone and DHEA . Plays a role in epidermal cholesterol metabolism and in the regulation of epidermal proliferation and differentiation . .; FUNCTION: [Isoform 2]: Sulfonates pregnenolone but not cholesterol. . |
Accessions | ENST00000323090.4 [O00204-2] O00204 ENST00000201586.7 [O00204-1] |